ArticleHuman gene therapy2013

Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.

Satiro Nakamura De Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.